SEC 13F Intelligence

Boxer Capital, LLC / TNGX

Boxer Capital, LLC’s Tango Therapeutics Inc Position

Does Boxer Capital, LLC own Tango Therapeutics Inc (TNGX)? Not currently — the last reported position was 8.20M shares worth $63M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$63M
Q3 2024
Shares
8.20M
% of Portfolio
+3.10%
Quarters Held
13
position exited

Position History TNGX

Reported value by quarter
Q3 ’21: $89MQ3 ’21Q4 ’21: $75MQ1 ’22: $52MQ1 ’22Q2 ’22: $31MQ3 ’22: $25MQ3 ’22Q4 ’22: $52MQ1 ’23: $28,138Q1 ’23Q2 ’23: $23,650Q3 ’23: $80MQ3 ’23Q4 ’23: $81MQ1 ’24: $65MQ1 ’24Q2 ’24: $70MQ3 ’24: $63MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20248.20M$63M+3.10%
Q2 20248.20M$70M+3.70%
Q1 20248.20M$65M+3.22%
Q4 20238.20M$81M+4.05%
Q3 20237.12M$80M+4.27%
Q2 20237.12M$23,650+1.10%
Q1 20237.12M$28,138+1.38%
Q4 20227.12M$52M+2.72%
Q3 20226.87M$25M+1.40%
Q2 20226.87M$31M+1.97%
Q1 20226.87M$52M+2.68%
Q4 20216.87M$75M+2.92%
Q3 20216.87M$89M+3.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of TNGX.